Continuing education course# 2: current understanding of hemostasis

AJ Gale - Toxicologic pathology, 2011 - journals.sagepub.com
The goal of this review is to briefly summarize the two primary pathways of hemostasis,
primary hemostasis and secondary hemostasis, as well as to summarize anticoagulant …

Disseminated intravascular coagulation

M Levi, E de Jonge, T van der Poll… - Thrombosis and …, 1999 - thieme-connect.com
A quick literature search in the MEDLINE databases from 1966 to 1998 using the search
term disseminated intravascular coagulation (DIC) and related key words yields an …

[HTML][HTML] High levels of coagulation factor XI as a risk factor for venous thrombosis

JCM Meijers, WLH Tekelenburg… - … England Journal of …, 2000 - Mass Medical Soc
Background Factor XI, a component of the intrinsic pathway of coagulation, contributes to the
generation of thrombin, which is involved in both the formation of fibrin and protection …

Oral contraceptives and the risk of venous thrombosis

JP Vandenbroucke, J Rosing… - … England Journal of …, 2001 - Mass Medical Soc
In the early 1960s, shortly after the introduction of oral contraceptives, the first case reports
appeared describing venous thrombosis and pulmonary emboli in women using this method …

[HTML][HTML] Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation

C Maas, JWP Govers-Riemslag… - The Journal of …, 2008 - Am Soc Clin Investig
When blood is exposed to negatively charged surface materials such as glass, an enzymatic
cascade known as the contact system becomes activated. This cascade is initiated by …

[HTML][HTML] Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

BN Bouma, JCM Meijers - Journal of Thrombosis and Haemostasis, 2003 - Elsevier
Recently, a new inhibitor of fibrinolysis was described, which downregulated fibrinolysis
after it was activated by thrombin, and was therefore named TAFI (thrombin-activatable …

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

BN Bouma, PF Marx, LO Mosnier, JCM Meijers - Thrombosis research, 2001 - Elsevier
Recently, a new inhibitor of fibrinolysis was described. This inhibitor downregulated
fibrinolysis after it was activated by thrombin, and was therefore named TAFI (thrombin …

Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin

LO Mosnier, JCM Meijers… - Thrombosis and …, 2001 - thieme-connect.com
Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like proenzyme,
that after activation down regulates fibrinolysis. TAFI is activated by thrombin in the presence …

Thrombin activatable fibrinolysis inhibitor (TAFI)—how does thrombin regulate fibrinolysis?

BN Bouma, LO Mosnier - Annals of medicine, 2006 - Taylor & Francis
The thrombin‐catalysed conversion of plasma fibrinogen into fibrin and the development of
an insoluble fibrin clot are the final steps of the coagulation cascade during haemostasis. A …

The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration

LO Mosnier, T Lisman, MH Berg… - Thrombosis and …, 2001 - thieme-connect.com
TAFI (thrombin activatable fibrinolysis inhibitor) down regulates fibrinolysis after activation by
relatively high concentrations of thrombin generated during coagulation via thrombin …